61 related articles for article (PubMed ID: 16768229)
1. [Treatment of non-psychotic depression in outpatient clinic].
Ivanets NN; Kinkul'kina MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(5):60-2. PubMed ID: 16768229
[No Abstract] [Full Text] [Related]
2. The role of paroxetine in fatigue and depression of patients under chemotherapeutic treatment.
Heras P; Kritikos K; Hatzopoulos A; Kritikos N; Heras V; Mitsibounas D
Am J Ther; 2013; 20(3):254-6. PubMed ID: 19262364
[TBL] [Abstract][Full Text] [Related]
3. Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression.
Lee YM; Lee KU
Psychiatry Clin Neurosci; 2011 Dec; 65(7):630-7. PubMed ID: 22176282
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety.
Chaudhry HR; Qureshi Z; Tareen IA; Yazdani I
J Pak Med Assoc; 2002 Nov; 52(11):518-25. PubMed ID: 12585372
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.
Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E
Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M
Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
[TBL] [Abstract][Full Text] [Related]
7. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
Baldwin DS; Hawley CJ; Abed RT; Maragakis BP; Cox J; Buckingham SA; Pover GH; Ascher A
J Clin Psychiatry; 1996; 57 Suppl 2():46-52. PubMed ID: 8626363
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of paroxetine and imipramine in depressed outpatients.
Melton ST; Kirkwood CK; Farrar TW; Brink DD; Carroll NV
Psychopharmacol Bull; 1997; 33(1):93-100. PubMed ID: 9133757
[TBL] [Abstract][Full Text] [Related]
9. Do new-generation antidepressants work?
Kelly BD
Ir Med J; 2008 May; 101(5):155. PubMed ID: 18624267
[No Abstract] [Full Text] [Related]
10. Depression and psoriasis comorbidity. Treatment with paroxetine: two case reports.
Luis Blay S
Ann Clin Psychiatry; 2006; 18(4):271-2. PubMed ID: 17162628
[No Abstract] [Full Text] [Related]
11. Superiority of escitalopram to paroxetine in the treatment of depression.
Kasper S; Baldwin DS; Larsson Lönn S; Boulenger JP
Eur Neuropsychopharmacol; 2009 Apr; 19(4):229-37. PubMed ID: 19185467
[TBL] [Abstract][Full Text] [Related]
12. Paroxetine serum concentrations in depressed patients and response to treatment.
Gilles M; Deuschle M; Kellner S; Shams M; Krumm B; Härtter S; Heuser I; Hiemke C
Pharmacopsychiatry; 2005 May; 38(3):118-21. PubMed ID: 15902581
[TBL] [Abstract][Full Text] [Related]
13. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
[TBL] [Abstract][Full Text] [Related]
14. [Application of antidepressant to treat patients in the department of otolaryngology].
Goto F; Tsutsumi T; Ogawa K
Nihon Rinsho; 2012 Jan; 70(1):115-21. PubMed ID: 22413504
[TBL] [Abstract][Full Text] [Related]
15. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.
Szegedi A; Kohnen R; Dienel A; Kieser M
BMJ; 2005 Mar; 330(7490):503. PubMed ID: 15708844
[TBL] [Abstract][Full Text] [Related]
16. Drugs or psychotherapy for the elderly?
Harv Ment Health Lett; 2001 Oct; 18(4):7. PubMed ID: 11684507
[No Abstract] [Full Text] [Related]
17. Efficacy of paroxetine for the treatment of depression in the context of HIV infection.
Grassi B; Gambini O; Garghentini G; Lazzarin A; Scarone S
Pharmacopsychiatry; 1997 Mar; 30(2):70-1. PubMed ID: 9131727
[TBL] [Abstract][Full Text] [Related]
18. Increased concentration of corticosteroid-binding globulin due to antidepressant treatment with amitritpyline, but not paroxetine.
Deuschle M; Luppa P; Hamann B; Nonell A; Heuser I
J Psychiatr Res; 2003; 37(1):85-7. PubMed ID: 12482473
[No Abstract] [Full Text] [Related]
19. Time course of response to paroxetine: influence of plasma level.
Gex-Fabry M; Gervasoni N; Eap CB; Aubry JM; Bondolfi G; Bertschy G
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):892-900. PubMed ID: 17395353
[TBL] [Abstract][Full Text] [Related]
20. Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.
Hwang JP; Yang CH; Tsai SJ
Int J Geriatr Psychiatry; 2004 Feb; 19(2):189-90. PubMed ID: 14758586
[No Abstract] [Full Text] [Related]
[Next] [New Search]
